Certain pyrido-pyrimidines for treating mammalian and avian infections
First Claim
Patent Images
1. A method of treating an infection in a mammalian or avian host caused by E. coli which utilizes de novo synthesis of riboflavin which comprises the step of administering to a mammalian or avian host having an infection caused by E. coli which utilizes de novo synthesis of riboflavin a therapeutically effective treatment dose for said infection of a compound of formula B ##STR15## where R1 is alkyl or hydroxyalkyl having 1 to 6 carbon atoms, and wherein R2, R3 and R4 are the same or different and each is hydrogen or alkyl of 1 to 4 carbon atoms or a pharmaceutically acceptable salt thereof.
0 Assignments
0 Petitions
Accused Products
Abstract
8-Substituted pyrido [2,3-d]pyrimidines having activity against microorganisms which utilize de novo synthesis of riboflavin.
9 Citations
3 Claims
- 1. A method of treating an infection in a mammalian or avian host caused by E. coli which utilizes de novo synthesis of riboflavin which comprises the step of administering to a mammalian or avian host having an infection caused by E. coli which utilizes de novo synthesis of riboflavin a therapeutically effective treatment dose for said infection of a compound of formula B ##STR15## where R1 is alkyl or hydroxyalkyl having 1 to 6 carbon atoms, and wherein R2, R3 and R4 are the same or different and each is hydrogen or alkyl of 1 to 4 carbon atoms or a pharmaceutically acceptable salt thereof.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeBurroughs Wellcome Co. (GlaxoSmithKline PLC)
-
Original AssigneeBurroughs Wellcome and Co.
-
InventorsPaterson, Thomas, Wood, Hamish Christopher Swan
-
Primary Examiner(s)Turner, V. D.
-
Application NumberUS05/335,102Time in Patent Office2,027 DaysField of Search424/180, 424/251, 260/211.5, 260/256.4US Class Current514/43CPC Class CodesC07D 471/04 Ortho-condensed systemsC07H 19/06 Pyrimidine radicals
